Good news, too bad they don't disclose the mechanism of action!
They tell us it acts on mTOR pathway (we know this already).
They tell us it defines a new and unexpected mechanism which is a potentially new class of anti-cancer drug.
They tell us that because of this mechanism of action it has very low toxicity and has a very low EC50.
This is driving me nuts with anticipation, the academic in me is dying to know how this works.
Ann: Second Cancer Patient Completes Course With Stable Disease, page-2
-
- There are more pages in this discussion • 33 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NUZ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $93.42M | |||
| Open | High | Low | Value | Volume |
| 19.0¢ | 19.3¢ | 19.0¢ | $36.02K | 189.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 8997 | 19.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 19.5¢ | 290222 | 5 |
View Market Depth
| Last trade - 15.58pm 06/11/2024 (20 minute delay) ? |
| NUZ (ASX) Chart |